Neurology's Broader Promise: An Exclusive Interview with Christopher Reeve

Published on: 

Pharmaceutical Executive

Pharmaceutical Executive, Pharmaceutical Executive-02-01-2001, Volume 0, Issue 0

During our conversation, Reeve pushes an even broader agenda: getting pharmaceutical companies to realize the huge market potential in spinal-cord research for a host of neurological conditions. He implores companies to put their attention, and their investment, into enterprises that are creating breakthroughs in new technologies promising wide therapeutic application.